PsiOxus Therapeutics PsiOxus - a great place to work - PsiOxus Therapeutics

Home
Contact

PsiOxus – a great place to work!

Comments are closed.

Vision & Strategy

Vision & Strategy

We aim to be the world's leading cancer gene therapy company.

Technology & Products

T-SIGn Platform & Products

View our advanced pipeline of products.

Clinical Trials

Clinical Trials

View information on our clinical trials here.

People & Investors

People & Investors

PsiOxus brings together highly experienced management and investors.

Latest News & Events

PsiOxus Therapeutics Announces First-in-Human Dosing of their Second Gene Therapy Cancer Treatment.

13th March 2019

PsiOxus Therapeutics to Collaborate with the Parker Institute for Cancer Immunotherapy

15th November 2018

PsiOxus Therapeutics Appoints Melissa Epperly as Chief Financial Officer

4th June 2018

logo

Email
Links
Sitemap
Privacy Policy

Copyright

Designed and Produced by www.imageworks.co.uk
© Copyright 2019 PsiOxus Therapeutics

© Copyright 2019 PsiOxus Therapeutics

RSS

About
Products and Platform
- Pipeline
- Enadenotucirev
- T-SIGn Platform
- NG-348
- NG-350A
- NG-641
- Publications
Clinical Trials
News & Events
- PsiOxus in the News
Contact

Responsive Menu Pro Image

Responsive Menu Clicked Image

Menu